Alternatives to Majesty Therapeutics, .

Clinical-stage biotechnology company developing Antibody Oligonucleotide Conjugates (AOCs) for serious diseases.

Gene therapy company developing treatments for rare inherited diseases.

Develops advanced gene editing and cell therapy solutions for rare genetic diseases.

Clinical-stage genetic medicine company developing AAV-mediated treatments for cardiovascular and Alzheimer's diseases.

Clinical-stage biopharmaceutical company developing gene therapies for rare genetic diseases.

Biotechnology company developing gene therapies and regenerative medicine for heart disease.

Biotech company developing next-generation gene writing tools for advanced therapies.

Developing novel therapeutics for rare genetic diseases with a focus on protein degradation.

Gene therapy company developing transformative treatments for severe genetic diseases.

Ridge Bio is developing a novel gene therapy platform for treating rare genetic diseases.

A clinical-stage biotechnology company developing transformative genome editing medicines for serious diseases.

Epicrispr Biotechnologies is a biotechnology company developing novel epigenetic therapies, with a lead program targeting Facioscapulohumeral Muscular Dystrophy (FSHD).

A clinical-stage genome editing company developing novel therapies using CRISPR/Cas9 technology for severe diseases.

A biotechnology company developing gene therapy treatments for rare, debilitating genetic diseases.

Leveraging the adaptive immune system to diagnose and treat disease.

A global oncology company developing and commercializing innovative cancer treatments.

Phenomics-driven AI company translating disease biology into precision medicine discoveries.

Mapping cell-cell communication at scale in human tissue.

AI-powered biotechnology company developing RNA therapeutics for genetic diseases.

Caris Life Sciences is a leading innovator in molecular science, offering precision medicine solutions for cancer patients through advanced molecular profiling.